Last SFr.105.30 CHF
Change Today +2.90 / 2.83%
Volume 1.4M
ATLN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
As of 11:19 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elias Adam Zerhouni M.D.

President of Global Research & Development at Sanofi-aventis, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 104 board members in 6 different organizations across 6 different industries.

See Board Relationships
63--

Background*

Dr. Elias Adam Zerhouni, M.D has been the President of Global Research and Development at Sanofi since January 2011. Dr. Zerhouni serves as a Consultant. He serves as Senior Advisor of Johns Hopkins University School of Medicine. Dr. Zerhouni served as Managing Director of Sanofi-aventis. He served as a Principal Investigator on three NIH grants and Co-investigator on two others. He served as a Consultant to the World Health Organization since 1988. He served as a Consultant ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Director
Emeritus Public Trustee
Member of Board of Trustees
2002-2008
Former Director
2009-2010
President of Global Research & Development at Sanofi-aventis
2009-Present
Director and Member of Nominating & Governance Committee

Education*

Unknown/Other Education 1978
Johns Hopkins University
MD 1975
University Of Algiers

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.105.30 CHF +2.90

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$992.7K
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Jörg-Thomas Dierks Chief Executive Officer
Meda AB
kr2.1M
Timo Lappalainen M.Sc. (Ind. Eng.)Chairman of the Executive Management Board, Chief Executive Officer and President
Orion Oyj
€1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.